Document is current
Any future updates will be listed below
-
Authors
Teramoto, Masahiro https://orcid.org/0000-0002-7569-6888
Shimomura, Yoshimitsu https://orcid.org/0000-0003-1018-9508
Hosoi, Hiroki
Yanada, Masamitsu https://orcid.org/0000-0003-1602-9775
Mizuno, Shohei https://orcid.org/0000-0002-4405-8808
Uchida, Naoyuki https://orcid.org/0000-0001-5952-5926
Mori, Yasuo https://orcid.org/0000-0001-6425-1720
Doki, Noriko https://orcid.org/0000-0002-8661-3179
Takeda, Wataru
Katayama, Yuta https://orcid.org/0000-0001-5054-9104
Ota, Shuichi https://orcid.org/0000-0002-3631-244X
Nakamae, Hirohisa https://orcid.org/0000-0003-4203-990X
Kuriyama, Takuro https://orcid.org/0000-0001-7375-3183
Yoshihara, Satoshi https://orcid.org/0000-0002-8537-2422
Toyosaki, Masako
Imada, Kazunori https://orcid.org/0000-0002-0945-0513
Sakata-Yanagimoto, Mamiko https://orcid.org/0000-0001-7310-8045
Onizuka, Makoto https://orcid.org/0000-0003-3864-0823
Kanda, Junya https://orcid.org/0000-0002-6704-3633
Fukuda, Takahiro
Atsuta, Yoshiko https://orcid.org/0000-0003-4404-2870
Konuma, Takaaki https://orcid.org/0000-0002-1953-8463
- License Information
-
More Information
Article History
Received: 14 February 2025
Revised: 13 May 2025
Accepted: 29 May 2025
First Online: 9 June 2025
Competing interests
: SM received research funding from Hayashikane Sangyo and a lecture fee from Janssen Pharmaceutical. The other authors declare no conflicts of interest.
: All methods were performed in accordance with the Declaration of Helsinki and relevant guidelines and regulations. This study was approved by the Institutional Review Board of Hyogo Medical University (approval number: 4698). All participating patients provided written informed consent to the Japanese Society for Transplantation and Cellular Therapy at the time of registration.
